Abstract:
When the American Academy of Pediatrics published the new clinical guidelines for evaluation and treatment of pediatric obesity in 2023 it placed an emphasis on using pharmacotherapy early in the care of patients. This has required a cultural shift in the practice of pediatrics. Many providers have not received adequate exposure and training for use of these medications, and therefore the guidelines have not been universally applied. Through clinical practice in applying AAP guidelines I have developed a systematic, thoughtful, and individualized approach for using pharmacotherapy in pediatrics and aim to share it with other practicing providers to better serve our patients with obesity.
Biography:
Dr. Green is board certified in pediatric endocrinology and obesity medicine. She completed her pediatric residency at Johns Hopkins and fellowship at Children’s Hospital of Philadelphia. She specializes in treating pediatric obesity and metabolic syndrome conditions at both Kennedy Krieger and Johns Hopkins Children's Center. Her clinical activities include directing of the Fit and Healthy Kids Multidisciplinary Clinic at Kennedy Krieger Institute, a clinic designed to treat elevated weight in children with physical or cognitive diVerences and disabilities. Additionally, she designed and directs the bi-weekly Healthy Families Program at Johns Hopkins Children's Center, a biweekly lifestyle medicine group.
